Biofinity Sphere
FDA premarket approval P080011/S155 · decided 2023-08-09
Approval details
- PMA number
- P080011
- Supplement
- S155
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Biofinity Sphere
- Generic name
- Lenses, soft contact, extended wear
- Applicant
- CooperVision, Inc.
- Date received
- 2023-07-11
- Decision date
- 2023-08-09
- Days to decision
- 29 days
- Decision code
- OK30
- Product code
- LPM
- Advisory committee
- Ophthalmic
- Expedited review
- No
- Location
- San Ramon, CA
- Statement
- Introduction of a High Volume (HV) Biofinity dry line and wet line installed at the CooperVision Manufacturing, Ltd. facility in Hamble, UK to produce Biofinity Sphere lenses.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.